Provided by Tiger Trade Technology Pte. Ltd.

West Pharmaceutical

250.49
+6.882.82%
Post-market: 250.490.00000.00%19:37 EST
Volume:980.27K
Turnover:243.52M
Market Cap:18.02B
PE:37.10
High:250.53
Open:243.94
Low:242.14
Close:243.61
52wk High:322.34
52wk Low:187.43
Shares:71.94M
Float Shares:71.41M
Volume Ratio:0.65
T/O Rate:1.37%
Dividend:0.84
Dividend Rate:0.34%
EPS(TTM):6.75
EPS(LYR):6.69
ROE:16.85%
ROA:9.68%
PB:5.67
PE(LYR):37.44

Loading ...

West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 14

West Pharma Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Feb 14

UBS Adjusts West Pharmaceutical Services Price Target to $340 From $355, Maintains Buy Rating

MT Newswires Live
·
Feb 14

Barclays Adjusts West Pharmaceutical Services PT to $265 From $325, Maintains Equal Weight Rating

MT Newswires Live
·
Feb 13

West Pharmaceutical price target lowered to $340 from $355 at UBS

TIPRANKS
·
Feb 13

West Pharmaceutical Services Inc : Barclays Cuts Target Price to $265 From $325

THOMSON REUTERS
·
Feb 13

West Pharmaceutical Services Signals HVP‑Led Growth Ahead

TIPRANKS
·
Feb 13

BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National

Reuters
·
Feb 13

Stock Track | West Pharmaceutical Plummets 7.52% Intraday Despite Earnings Beat as Growth Concerns Surface

Stock Track
·
Feb 13

West Pharmaceutical Services Shares up 2.8% After Upbeat 2026 Profit Forecast

THOMSON REUTERS
·
Feb 12

West Pharmaceutical: Strong Quarterly Beat and Confident 2026 Outlook Support Buy Rating Despite GLP‑1 Concerns

TIPRANKS
·
Feb 12

BUZZ-U.S. STOCKS ON THE MOVE-PPG Industries, American Electric Power, West Pharmaceutical

Reuters
·
Feb 12

West Pharmaceutical Shares up 4.5% Premarket After Co Forecasts 2026 Profit Above Estimates

THOMSON REUTERS
·
Feb 12

West Pharma Exec Says It Continues to Expect Growth From Both Injectable and Oral Forms of Glp-1 in 2026 - Conf Call

THOMSON REUTERS
·
Feb 12

West Pharma Exec Says Glp‑1 Demand Expected to Grow in 2026, Though at a Slower Pace Than 2025 - Conf Call

THOMSON REUTERS
·
Feb 12

West Pharma Exec Says Co Sees No Change in Customer Behavior and Describes Its Annual Forecast as a Conservative Start- Conf Call

THOMSON REUTERS
·
Feb 12

West Pharma Exec Says Co Expects 2026 Will Have "Broad Based Growth Profile" Driven by Non Glp-1 Hvp Components Growing High Single Digits to Low Single Digits - Conf Call

THOMSON REUTERS
·
Feb 12

West Pharma Exec Says Glp‑1 Adoption Would Need to Exceed 30% to Reach 10% Year-Over-Year Growth for Co - Conf Call

THOMSON REUTERS
·
Feb 12

BUZZ-West Pharmaceuticals rises after upbeat 2026 profit forecast

Reuters
·
Feb 12

West Pharma forecasts 2026 profit above estimates on strong demand for drug components

Reuters
·
Feb 12